Cerebrospinal and plasma amino acid concentrations after administration of IV glycyl-glutamine and glycyl-tyrosine containing amino acid solutions in humans

Journal of Parenteral and Enteral Nutrition

Volumn 20, Issue 4, 1996, Pages 281-286

  Himmelseher, Sabine ^a   Pfenninger, Ernst ^a   Herrmann, Petra ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUTAMINE; GLYCINE; TYROSINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOTAL PARENTERAL NUTRITION;

EID: 0029817203     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607196020004281     Document Type: Article

References (38)

1. Adibi SA, Lochs H, Abumrad NN, et al: Removal of glycyl-glutamine from plasma by individual tissue: Mechanism and impact on amino acid fluxes in postabsorption and starvation. J Nutr 123:325-331, 1993
2. Furst P, Stehle P: The potential use of parenteral dipeptides in clinical nutrition. NCP 8:106-114, 1993
3. Vazquez JA, Daniel H, Adibi SA: Dipeptides in parenteral nutrition: From basic science to clinical applications. NCP 8:95-105, 1993
4. Jiang ZM, Wang LJ, Qi Y, et al: Comparison of parenteral nutrition supplemented with L-glutamine or glutamine dipeptides. JPEN 17:134-140, 1993
5. Lacey JM, Wilmore DW: Is glutamine a conditionally essential amino acid? Nutr Rev 48:297-309, 1990
6. Parry-Billings M, Baigrie RJ, Lamont PM, et al: Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg 127:1237-1240, 1992
7. Van der Hulst RRWJ, Van Kreel BK, Meyenfeldt MF, et al: Glutamine and the preservation of gut integrity. Lancet 341:1363-1365, 1993
8. Wilmore DW: Catabolic illness - strategies for enhancing recovery. N Engl J Med 325:342-345, 1991
9. Carlsson A, Lindqusit M: Dependence of 5-HT and catecholamine synthesis on concentrations of precusor amino-acids in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 303:157-164, 1978
10. Dabees T, Stegnik L: L-Alanyl-L-tyrosine as a tyrosine source during total parenteral nutrition. Infusion at 0.5 and 2 mmoles/kg/day in adult rats. Pediatr Res 13:894-899, 1979
11. Stehle P, Zander J, Mertes N, et al: Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet 1:231-233, 1989
12. Ziegler TR, Young LS, Benfell K, et al: Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized double blind controlled study. Ann Intern Med 116:821-828, 1992
13. Albers S, Wernermann J, Stehle P, et al: Availability of amino acids supplied by constant intravenous infusion of synthetic dipeptides in healthy man. Clin Sci 76:643-648, 1989
14. Brandl M, Sailer D, Langer K, et al: Parenteral nutrition with an amino acid solution containing a mixture of dipeptides. Evidence for efficient utilization of dipeptides in man. Contr Infusion Ther Clin Nutr 17:103-116, 1987
15. Huebl W, Druml W, Langer K, et al: Influence of molecular structure and plasma hydrolysis on the metabolism of glutamine-containing dipeptides in humans. Metabolism 38 (Suppl 1):59-62, 1989
16. Lochs H, Huebl W, Gasic S, et al: Glycyl-glutamine: metabolism and effects on organ balances of amino acids in postabsorptive and starved subjects. Am J Physiol 262:E155-160, 1992
17. Adibi SA: Glycyl-dipeptides: New substrates for protein nutrition. J Lab Clin Med 113:665-673, 1989
18. Triguero D, Buciak J, Pardridge WM: Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 54:1882-1888, 1990
19. Zlokovic B, Begley DJ, Chain DG: Blood-brain barrier permeability to dipeptides and their constituent amino acids. Brain Res 271:65-71, 1983
20. Battie CN, Hagler KE, Millington WR: Glycyl-L-glutamine regulates the expression of asymmetric acetylcholinesterase molecular forms in cultured cardiac postnatal myocytes. J Mol Cell Cardiol 25:1111-1118, 1996
21. Haynes L: β-Endorphin C-terminal peptide evokes arachidonic acid release from cortical neurones. Eur J Pharmacol 192:397-401, 1991
22. Hirsch MD, O'Donohue TL: Structural modifications of propiomelanocortin-derived peptides alter their behavioral effects markedly. J Pharmacol Exp Ther 237:378-385, 1986
23. Koelle GB, Massoulie J, Eugene D, et al: Effects of glycyl-L-glutamine in vitro on the molecular forms of acetylcholinesterase in the preganglionally denervated superior cervical ganglion in the cat. Proc Natl Acad Sci USA 85:1686-1690, 1988
24. 12 acetylcholinesterase but not of nicotinic acetylcholine receptors in quail embryonic myotubes by a cyclic AMP-independent mechanism. J Neurochem 54:1122-1129, 1990
25. McChain HW, Lamster IB, Bilotta CB: Modulation of human T-cell suppressor activity by beta endorphin and glycyl-L-glutamine. Int J Immunopharmacol 8:443-446, 1986
26. Parish DC, Smyth DG, Normanton JR, et al: Glycyl-glutamine, an inhibitory neuropeptide derived from β-endorphin. Nature 306:267-270, 1983
27. Resch GE, Millington WR: Glycyl-L-glutamine antagonizes α-MSH-elicited thermogenesis. Peptides 14:971-975, 1993
28. Folstein MF, Folstein SE, McHuge PR: "Minimal mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198, 1975
29. Spackman DH, Stein WH, Moore S: Automatic recording apparatus for use in the chromatography of amino acids. Analyt Chem 30:1190-1206, 1958
30. Kruse T, Reiber H, Neuhoff V: Amino acid transport across the human blood-CSF barrier. J Neurol Sci 70:129-138, 1985
31. Kornhuber J, Kornhuber ME, Hartmann GM, et al: In vivo influences on cerebrospinal fluid amino acid levels. Neurochem Int 12:25-31, 1988
32. Adibi SA, Krzysik BA, Drash AL: Metabolism of intravenously administered dipeptides in rats: Effects on amino acid pools, glucose concentration and insulin and glucagon sectretion. Clin Sci Mol Med 52:193-204, 1977
33. Vazquez JA, Ragunath M, Adibi SA: Uptake and hydrolysis of glycyl-glutamine at the blood-brain barrier. Metabolism 41:121-124, 1992
34. Lochs H, Morse EL, Adibi SA: Uptake and metabolism of dipeptides in human red blood cells. Biochem J 271:133-137, 1990
35. McGale EHF, Pye IF, Stonier C, et al: Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 29:291-297, 1977
36. Oldendorf WH, Szabo J: Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am J Physiol 230:94-98, 1976
37. Choi TB, Pardridge WM: Phenylalanine transport at the human blood-brain barrier. J Biol Chem 261:6536-9541, 1986
38. Stover JF, Vrana S, Schaefer M, et al: Therapeutic procedures (anesthesia, parenteral nutrition) significantly influence plasma and CSF levels of excitotoxic amino acids in neurosurgical patients. J Cereb Blood Flow Metab 15 (Suppl 1):S428, 1995